Plasma biomarkers for prediction of sudden cardiac death: another piece of the risk stratification puzzle?

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 3622872)

Published in Circ Arrhythm Electrophysiol on February 01, 2012

Authors

Rasmus Havmöller1, Sumeet S Chugh

Author Affiliations

1: Cedars-Sinai Heart Institute, Los Angeles, CA 90048, USA.

Articles cited by this

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther (2001) 14.78

Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA (2008) 12.28

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

Sudden death due to cardiac arrhythmias. N Engl J Med (2001) 6.72

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89

Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation (2006) 4.35

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation (2002) 4.30

Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis (2008) 4.09

Predicting sudden death in the population: the Paris Prospective Study I. Circulation (1999) 3.80

Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol (2010) 3.45

Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol (2006) 3.44

Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation (2001) 3.12

Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation (2010) 2.94

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation (2002) 2.78

Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythm Electrophysiol (2011) 2.35

Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation (2009) 2.31

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet (1994) 1.99

Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J (2005) 1.88

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation (2002) 1.85

Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol (2004) 1.80

Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women. Circulation (2009) 1.74

Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J (2003) 1.67

Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation (2006) 1.64

Cystatin C and cardiovascular risk. Clin Chem (2009) 1.57

Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure. Eur Heart J (2011) 1.55

Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint. Prev Cardiol (2010) 1.49

N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study. Heart Rhythm (2010) 1.48

Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet (2011) 1.38

Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2010) 1.30

Risk factors for sudden cardiac death in middle-aged British men. Circulation (1995) 1.29

Diabetes as a risk factor for sudden death. Lancet (1999) 1.27

Early identification of risk factors for sudden cardiac death. Nat Rev Cardiol (2010) 1.27

Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis (2005) 1.19

Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study. Circulation (2010) 1.17

Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes (2010) 1.14

Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease. Circ Cardiovasc Genet (2011) 1.09

Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace (2007) 1.05

Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr (2010) 1.04

C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study. Arterioscler Thromb Vasc Biol (2010) 1.00

Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium. Cardiovasc Res (1997) 0.94

Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort. Arterioscler Thromb Vasc Biol (2009) 0.92

Multiple biomarkers for predicting cardiovascular events: lessons learned. J Am Coll Cardiol (2010) 0.89

The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling elderly: a systematic review. Age Ageing (2009) 0.88

ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases. Atherosclerosis (2006) 0.82

Predicting sudden death in the general population: another step, N terminal B-type natriuretic factor levels. Circulation (2009) 0.81

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol (2006) 3.44

Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation (2010) 2.94

Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging (2010) 2.86

Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythm Electrophysiol (2011) 2.35

Socioeconomic status and incidence of sudden cardiac arrest. CMAJ (2011) 2.31

Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA (2005) 2.07

Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging (2007) 1.86

Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. Heart Rhythm (2011) 1.73

Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community. Circulation (2013) 1.72

Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization. Heart Rhythm (2011) 1.69

Resting heart rate and risk of sudden cardiac death in the general population: influence of left ventricular systolic dysfunction and heart rate-modulating drugs. Heart Rhythm (2013) 1.56

Biological pacemaker created by percutaneous gene delivery via venous catheters in a porcine model of complete heart block. Heart Rhythm (2012) 1.54

Warning Symptoms Are Associated With Survival From Sudden Cardiac Arrest. Ann Intern Med (2016) 1.49

Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care (2009) 1.49

A common missense variant in the neuregulin 1 gene is associated with both schizophrenia and sudden cardiac death. Heart Rhythm (2013) 1.47

Contribution of sudden cardiac death to total mortality in India - a population based study. Int J Cardiol (2010) 1.43

Spontaneously alternating forms of the atrioventricular node reentrant tachycardia. Pacing Clin Electrophysiol (2011) 1.42

Genomics in sudden cardiac death. Circ Res (2004) 1.42

Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet (2011) 1.38

Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol (2011) 1.36

Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol (2014) 1.30

Incidence of sudden cardiac arrest is higher in areas of low socioeconomic status: a prospective two year study in a large United States community. Resuscitation (2006) 1.25

Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop. Circulation (2013) 1.18

Electrophysiological characteristics of focal atrial tachycardia surrounding the aortic coronary cusps. Circ Arrhythm Electrophysiol (2011) 1.18

Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study. Circulation (2010) 1.17

Risk stratification for sudden cardiac death: a plan for the future. Circulation (2014) 1.14

Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease. Circ Cardiovasc Genet (2011) 1.09

Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest. PLoS One (2010) 1.09

Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation. J Am Heart Assoc (2012) 0.98

Low rate of secondary prevention ICDs in the general population: multiple-year multiple-source surveillance of sudden cardiac death in the Oregon Sudden Unexpected Death Study. J Cardiovasc Electrophysiol (2012) 0.98

American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. Circulation (2011) 0.97

Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test? Circ Arrhythm Electrophysiol (2013) 0.94

Physical activity as a trigger of sudden cardiac arrest: the Oregon Sudden Unexpected Death Study. Int J Cardiol (2008) 0.94

Global remodeling of the ventricular interstitium in idiopathic myocardial fibrosis and sudden cardiac death. Heart Rhythm (2004) 0.94

Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm (2006) 0.92

Mapping and ablation of ventricular tachycardia from the left upper fascicle: how to make the most of the fascicular potential? Circ Arrhythm Electrophysiol (2013) 0.92

Atrial tachycardia originating from the left coronary cusp near the aorto-mitral junction: anatomic considerations. Heart Rhythm (2010) 0.90

Distinctive profile of sudden cardiac arrest in middle-aged vs. older adults: a community-based study. Int J Cardiol (2013) 0.89

Prediction of sudden cardiac death: next steps in pursuit of effective methodology. J Interv Card Electrophysiol (2011) 0.89

Relationship between seizure episode and sudden cardiac arrest in patients with epilepsy: a community-based study. Circ Arrhythm Electrophysiol (2013) 0.88

Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients. Europace (2006) 0.87

Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease. PLoS One (2013) 0.87

Electrocardiographic predictors of sudden cardiac death in patients with left ventricular hypertrophy. Ann Noninvasive Electrocardiol (2012) 0.85

Iron deposition following chronic myocardial infarction as a substrate for cardiac electrical anomalies: initial findings in a canine model. PLoS One (2013) 0.84

Survival advantage from ventricular fibrillation and pulseless electrical activity in women compared to men: the Oregon Sudden Unexpected Death Study. J Interv Card Electrophysiol (2012) 0.84

Arrhythmias after heart transplantation: mechanisms and management. J Am Heart Assoc (2012) 0.83

Prevention of esophageal thermal injury during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol (2012) 0.82

Apparent protective effect of increased left ventricular wall thickness in an ICD population. J Card Fail (2003) 0.82

Inducibility of atrial fibrillation in the absence of atrial fibrillation: what does it mean to be normal? Heart Rhythm (2010) 0.81

Predicting sudden death in the general population: another step, N terminal B-type natriuretic factor levels. Circulation (2009) 0.81

Arrhythmias after orthotopic heart transplantation. J Card Fail (2005) 0.80

Approach to the difficult septal atrioventricular accessory pathway: the importance of regional anatomy. Circ Arrhythm Electrophysiol (2012) 0.78

An intersection of atrial fibrillation with sudden death: look both ways, and proceed with caution. JAMA Intern Med (2013) 0.77

Antipsychotic drugs are associated with pulseless electrical activity: the Oregon Sudden Unexpected Death Study. Heart Rhythm (2012) 0.77

Unexplained sudden cardiac death: an opportunity to identify hereditary cardiac arrhythmias. Eur Heart J (2011) 0.77

Approach to unexplained sudden death in the young: proactive during life and prospective at death. Europace (2011) 0.76

Genomics revolution: forging a path to the arrhythmia patient. Heart Rhythm (2010) 0.75

Atrial fibrillation in heart failure. Curr Heart Fail Rep (2012) 0.75

Identifying the high-risk Brugada syndrome patient: let us get personal. Heart Rhythm (2012) 0.75

Confronting the genetic complexity of atrial fibrillation: this too shall pass. Heart Rhythm (2007) 0.75

Nonautomatic focal atrial tachycardia: characterization and ablation of a poorly understood arrhythmia in 38 patients. Pacing Clin Electrophysiol (2003) 0.75

Sudden cardiac arrest. CMAJ (2012) 0.75

Learning from a real-world analysis of implantable cardioverter-defibrillator recipients: comorbidities matter. J Am Coll Cardiol (2007) 0.75

HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011. Heart Rhythm (2011) 0.75

Potentials in the posterior fascicle: active role or passive bystander? J Cardiovasc Electrophysiol (2013) 0.75

A tale of two tachycardias--what is the mechanism? Pacing Clin Electrophysiol (2011) 0.75

Anomalous midline common ostium of the left and right inferior pulmonary veins: implications for pulmonary vein isolation in atrial fibrillation. Circ Arrhythm Electrophysiol (2008) 0.75

Unusual wide complex tachycardia: what is the mechanism? J Cardiovasc Electrophysiol (2010) 0.75

Prolonged QT and cardiac arrest after heart transplantation: inherited or acquired? J Electrocardiol (2011) 0.75